Inclusion of older women in randomized clinical trials: Factors associated with taking study medication in the fracture intervention trial

Journal of the American Geriatrics Society

Volumn 48, Issue 9, 2000, Pages 1126-1131

  Buist, Diana S M ^a   Lacroix, Andrea Z ^a   Black, Dennis M ^b   Harris, Fran ^b   Blank, Jan ^c   Ensrud, Kristine ^d   Edgerton, Donna ^a   Rubin, Susan ^b   Fox, Kathleen M ^e  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e Managed EDGE   (United States)

Author keywords

Adherence; Controlled trial; Intervention; Randomized clinical trials; Study withdrawal

Indexed keywords

ALENDRONIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 0033864422     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb04790.x     Document Type: Article

References (25)

1. Adherence to aspirin in the prevention of myocardial infarction: The Physicians' Health Study
2. Treatment adherence and risk of death after a myocardial infarction
3. Dropout in an outpatient, double-blind drug study
4. Discontinuation of antihyperlipidemic drugs - Do rates reported in clinical trials reflect rates in primary care settings?
5. Factors associated with medication noncompliance in rural elderly hypertensive patients
6. Compliance to treatment for hypertension in elderly patients: The SHEP pilot study. Systolic Hypertension in the Elderly Program
7. Drug therapy: Patient compliance
8. The drug defaulter
9. Diagnosis and management of patient noncompliance
10. Can categorization of patient background problems be used to determine early termination in a clinical trial
11. Adherence to lifestyle changes and pharmacotherapy among elderly individuals in clinical trials
12. For the Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on the risk of fracture in women with existing vertebral fractures
13. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study
14. The MOS 36-item short-form health survey (SF 36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
15. Geriatric Depression Scale
16. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version
17. Compliance with drug treatment
18. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
19. Estimating the effect of the run-in on the power of the Physicans' Health Study
20. A comprehensive algorithm for determining whether a run-in strategy will be a cost-effective design modification in a randomized clinical trial
21. Value of a run-in period in a drug trial during pregnancy
22. The drug regimen and treatment compliance
23. Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study of antihypertensive therapy: Mild hypertension